Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones
March 6 (Reuters) - Contineum Therapeutics Inc CTNM.O:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.